United States

Henan Taloph Pharmaceutical Stock Co Ltd (600222.SS)

600222.SS on Shanghai Stock Exchange

14 Feb 2018
Change (% chg)

¥-0.02 (-0.46%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Henan Taloph Pharmaceutical Stock Co., Ltd. is principally engaged in the research, development, manufacture and sale of traditional Chinese medicines and western pharmaceuticals. The Company offers oral solutions, transfusion and tablets, which are used for the treatment of cold, diabetes and virus infection. The Company... (more)
No analyst recommendations are available for .


Beta: 1.10
Market Cap(Mil.): ¥2,490.67
Shares Outstanding(Mil.): 573.89
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 32.03 17.27
EPS (TTM): -- -- --
ROI: -- 14.00 35.43
ROE: -- 15.34 17.10

BRIEF-Henan Taloph Pharmaceutical Stock passes review of high-tech enterprise recognition

* Says it passes the review of high-tech enterprise recognition and could enjoy a tax preference of 15 percent for three years

Feb 12 2018

BRIEF-Henan Taloph Pharmaceutical Stock unit receives GMP certificate

* Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Zhejiang Food and Drug Administration

Jan 30 2018

BRIEF-Henan Taloph Pharmaceutical Stock says change of accounting policy

* Says it changes accounting policy regarding government subsidy

Aug 20 2017

Earnings vs. Estimates